CHRISTOPHER ADER: Open Payments
NPI 1508141235 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 19 payments from 9 companies in 2025. Trend: 2023 $663 · 2024 $497 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $205 |
| Novo Nordisk Inc | 1 | $103 |
| E.R. Squibb & Sons, L.L.C. | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| PFIZER INC. | 1 | $36 |
| Baxter Healthcare | 2 | $32 |
| CORDIS US CORP. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $15 |
Products named: Kerendia, Wegovy, CAMZYOS, LEQVIO, VYNDAQEL, Hillrom - Cardiac Ambulatory Monitor, MYNX CONTROL VENOUS, ELIQUIS.
Industry payments across MI — which companies pay providers there.
